Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report

November 2020 | 35 pages | ID: E5EF40006A4EN
MarketLine

Abstracts

Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report

Summary

Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Enzymotec Ltd (Enzymotec), a subsidiary of Frutarom Industries Ltd., produces, and markets of nutritional ingredients and medical foods for the entire human life-cycle such as from infancy to old age. The company develops clinically-validated products including bio-functional, lipid-based compounds compounds which meet a wide range of consumer demands on optimal development, supplementation for nutritional deficiencies and needs, and the management of medical disorders and diseases. Its major products includes Infat, EnzyPS Solutions, Vayacog, Vayarin, Vayarol, NoctoPlex, LuciPlex, NoctoPlex for kids, and Addivance for kids. The company market products under Vayacog,INFAT,Vayarin, SHARP PS, SHARP PS GREEN,NOCTOPLEX, NOCTOPLEX for Kids, and LUCIPLEX brand names. The company has business presence in India, the US, China, and Sweden. Enzymotec is headquartered in Migdal HaEmek, Israel.

Scope

• Detailed information on Enzymotec Ltd required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Enzymotec Ltd in the form of a SWOT analysis
• An in-depth view of the business model of Enzymotec Ltd including a breakdown and examination of key business segments
• Intelligence on Enzymotec Ltd's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Enzymotec Ltd, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of Enzymotec Ltd and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Enzymotec Ltd as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Enzymotec Ltd's business structure, strategy and prospects.

Contents

Table of Contents
Company Snapshot
Enzymotec Ltd: Company Overview
Enzymotec Ltd: Overview and Key Facts
Enzymotec Ltd: Overview
Enzymotec Ltd: Key Facts
Enzymotec Ltd: Key Employees
Enzymotec Ltd: Major Products and Services
Enzymotec Ltd: Company History
Enzymotec Ltd: Management Statement
Enzymotec Ltd: Locations and Subsidiaries
Enzymotec Ltd: Key Competitors
Enzymotec Ltd: Company Analysis
Enzymotec Ltd: Business Description
Enzymotec Ltd: SWOT Analysis
Enzymotec Ltd: SWOT Overview
Enzymotec Ltd: Strengths
Enzymotec Ltd: Weaknesses
Enzymotec Ltd: Opportunities
Enzymotec Ltd: Threats
Enzymotec Ltd: Corporate Financial Deals Activity
Enzymotec Ltd: Financial Deals Overview
Enzymotec Ltd: Top Deals 2016 - 2020YTD*
Enzymotec Ltd: Advisors
Enzymotec Ltd: Top Legal Advisors
Enzymotec Ltd: Mergers and Acquisitions
Enzymotec Ltd: Private Equity and Ownership
Enzymotec Ltd: Recent Developments
Enzymotec Ltd: News and Events Summary
Enzymotec Ltd: Business Expansion
Enzymotec Ltd: Contracts
Enzymotec Ltd: Corporate Governance
Enzymotec Ltd: Financial Performance
Enzymotec Ltd: Market Developments
Enzymotec Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Enzymotec Ltd: Key Facts
Table 2: Enzymotec Ltd: Key Employees
Table 3: Enzymotec Ltd: Company History
Table 4: Enzymotec Ltd: Locations and Subsidiaries
Table 5: Enzymotec Ltd: Key Competitors
Table 6: Enzymotec Ltd: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Enzymotec Ltd: M&A Average Deal Size - Value (US$m)
Table 8: Enzymotec Ltd: Top Deals 2016 - 2020YTD*
Table 9: Enzymotec Ltd: Legal Advisor Ranking by Value (US$m)
Table 10: Enzymotec Ltd: M&A Volume and Value Trend (2016 - YTD*2020)
Table 11: Enzymotec Ltd: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 12: Enzymotec Ltd: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 13: Enzymotec Ltd: News and Events Summary
Table 14: Enzymotec Ltd: Business Expansion
Table 15: Enzymotec Ltd: Contracts
Table 16: Enzymotec Ltd: Corporate Governance
Table 17: Enzymotec Ltd: Financial Performance
Table 18: Enzymotec Ltd: Market Developments
Table 19: Enzymotec Ltd: Strategy and Operations

List Of Figures

LIST OF FIGURES

Figure 1: Enzymotec Ltd: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Figure 2: Enzymotec Ltd: M&A Average Deal Size - Value (US$m)
Figure 3: Enzymotec Ltd: M&A Volume and Value Trend (2016 - YTD*2020)
Figure 4: Enzymotec Ltd: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Figure 5: Enzymotec Ltd: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)